•  
  •  
 

Yan Efrata Sembiring, Department of Thoracic, Cardiac, and Vascular Surgery, Faculty of Medicine, Universitas Airlangga; Dr. Soetomo General Academic Hospital, Surabaya, Indonesia
Heroe Soebroto, Department of Thoracic, Cardiac, and Vascular Surgery, Faculty of Medicine, Universitas Airlangga; Dr. Soetomo General Academic Hospital, Surabaya, Indonesia
Ito Puruhito, Department of Thoracic, Cardiac, and Vascular Surgery, Faculty of Medicine, Universitas Airlangga; Dr. Soetomo General Academic Hospital, Surabaya, Indonesia
Dhihintia Jiwangga Suta Winarno, Department of Thoracic, Cardiac, and Vascular Surgery, Faculty of Medicine, Universitas Airlangga; Dr. Soetomo General Academic Hospital, Surabaya, Indonesia
I Gusti Agung Made Adnyanya Putra2, Thoracic, Cardiac, and Vascular Surgery Residency Program, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia
Sri Pramesthi Wisnu Bowo Negoro, Thoracic, Cardiac, and Vascular Surgery Residency Program, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia
Ketut Putu Yasa, Department of Thoracic, Cardiac, and Vascular Surgery, Faculty of Medicine, Universitas Udayana; Prof. Dr. IGNG Ngoerah Central General Hospital, Denpasar, Indonesia
Jeffrey Jeswant Dillon, Department of Cardiothoracic Surgery, Institut Jantung Negara, Kuala Lumpur, Malaysia
Hermanto Tri Joewono, Department of Obstetrics and Gynaecology, Rumah Sakit Universitas Airlangga, Surabaya, Indonesia ; Indonesian Society of Obstetricians and Gynecologists
Muhammad Adrianes Bachnas, Department of Obstetrics and Gynaecology, Faculty of Medicine, Dr. Moewardi General Hospital, Surakarta, Indonesia; Indonesian Society of Obstetricians and Gynecologists
Brahmana Askandar Tjokroprawiro, Department of Obstetrics and Gynaecology, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia; Dr. Soetomo General Academic Hospital, Surabaya, Indonesia ; Indonesian Society of Obstetricians and Gynecologists

ORCID ID

Yan Efrata Sembiring: https://orcid.org/0000-0002-1712-1816, Heroe Soebroto: https://orcid.org/0000-0001-7422-2624, Ito Puruhito: https://orcid.org/0000-0003-2292-5402, Dhihintia Jiwangga Suta Winarno: https://orcid.org/0000-0002-6767-0768, I Gusti Agung Made Adnyanya Putra2: https://orcid.org/0000-0001-6778-0038, Sri Pramesthi Wisnu Bowo Negoro: https://orcid.org/0009-0004-8436-414X, Ketut Putu Yasa: https://orcid.org/0000-0003-3186-0073, Jeffrey Jeswant Dillon: https://orcid.org/0009-0008-0244-9078

Abstract

Highlights: 1. This study systematically reviewed the efficacy, clinical outcomes, and safety of the splenorenal shunt procedure with a comprehensive and meticulous approach. 2. The splenorenal shunt procedure is an innovative surgical intervention that offers a viable option for the management of portal hypertension. Abstract Portal hypertension is the second most common gastrointestinal bleeding in cirrhosis and non-cirrhosis patients. The splenorenal shunt surgery is a potential intervention that may be considered for portal hypertension patients with clinical symptoms such as upper gastrointestinal bleeding caused by the rupture of gastro-esophageal varices. In this study, the researchers aimed to analyze the efficacy, clinical outcomes, and safety of splenorenal shunt surgery in portal hypertension patients. The sources were obtained from electronic search databases, including PubMed, Google Scholar, and ScienceDirect, using the keywords "Efficacy," "Safety," and "Clinical Outcomes." in relation to splenorenal shunt surgery in portal hypertension patients. The researchers set specific criteria for inclusion and exclusion to select the articles. This systematic review revealed the efficacy of the splenorenal shunt procedure with favorable outcomes. The success rate of splenorenal shunt surgery in reducing the clinical symptoms of portal hypertension varied between 66% and 100%. The prevailing complications observed in this study were shunt thrombosis, rebleeding, and thrombocytopenia. However, notable improvements could be achieved with general treatment. In terms of short- and long-term clinical outcomes, the splenorenal shunt procedure demonstrated favorable results. It can be concluded that splenorenal shunt surgery provides excellent clinical outcomes and should be considered a viable treatment option for patients with both cirrhotic and non-cirrhotic portal hypertension.

First Page

302

Last Page

312

DOI

10.20473/fmi.v59i3.48843

Publication Date

9-10-2023

Download

Share

COinS